This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Gennova Biopharmaceuticals Limited. Active years: 2019-2020.
Location History:
- Pune, IN (2019)
- Maharashtra, IN (2020)
Company Filing History:
Years Active: 2019-2020
Title: Arjun Raghuwanshi: Innovator in Biopharmaceuticals
Introduction
Arjun Raghuwanshi is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of biopharmaceuticals, particularly in the purification processes of recombinant proteins. With a total of 2 patents to his name, Raghuwanshi is recognized for his innovative approaches in this critical area of research.
Latest Patents
Raghuwanshi's latest patents include a purification process for the isolation and commercial production of recombinant TNK-tPA tenecteplase. This invention relates to a novel method of isolating and purifying tissue plasminogen activator and its variants, specifically TNK-tPA from CHO cells. The process is described as industrially applicable, simple, cost-effective, robust, and highly efficient for TNK-tPA purification. Another significant patent is for the process of purification of rHu-GCSF, which provides a novel, scalable, and industrially viable downstream process for the purification of recombinant human G-CSF.
Career Highlights
Arjun Raghuwanshi is currently associated with Gennova Biopharmaceuticals Limited, where he continues to advance his research and development efforts. His work focuses on improving the efficiency and effectiveness of biopharmaceutical production processes.
Collaborations
Raghuwanshi collaborates with talented professionals in his field, including Sanjay K Singh and Shrawan Singh Kumar. Their combined expertise contributes to the innovative projects at Gennova Biopharmaceuticals Limited.
Conclusion
Arjun Raghuwanshi stands out as an influential inventor in the biopharmaceutical industry, with his patents reflecting a commitment to advancing purification processes. His work not only enhances the production of vital therapeutic proteins but also showcases the importance of innovation in healthcare.